Transfusion Medicine Reviews
Volume 21, Issue 2 , Pages 159-163 , April 2007

Jon Van Rood: Pioneer at the Crossroad of Human Leukocyte Antigens and Transplantation

  • Jan Jansen

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Jan Jansen, MD, PhD, Indiana Blood and Marrow Transplantation, Beech Grove, IN 46205.

References 

  1. Gaillard PJ. Growth, differentiation, and functions of explants of some endocrine glands. Symp Soc Exp Biol (Number II) Growth. 1948;139
  2. Van Rood JJ. HLA and I. Annu Rev Immunol. 1993;11:1–28
  3. Dausset J, Nenna A. Présence d'une leuco-agglutinine dans le sérum d'une cas d'agranulocytose chronique. Compt Rend Soc Biol (Paris). 1952;146:1534–1546
  4. van Loghem JJ, Sauer AJ, Hart M, et al. Zeldzame immunologische afwijkingen als oorzaak van bloedtransfusie-reacties bij een lijder aan verworven hemolytische anemie Ned. Tijdschr Geneeskd. 1956;100:314–323
  5. Van Rood JJ, Eernisse JG, van Leeuwen A. Leukocyte antibodies in sera of pregnant women. Nature. 1958;181:1735–1736
  6. Dausset J. Iso-leuco-anticorps. Acta Haematol (Basel). 1958;20:156–166
  7. Van Rood JJ, van Leeuwen A. Leukocyte grouping, a method and its application. J Clin Invest. 1963;42:1382–1390
  8. van Leeuwen A, Schuit HRE, Van Rood JJ. Typing for MLC (LD): II. The selection of nonstimulator cells by MLC inhibition tests using SD-identical stimulator cells (MISIS) and fluorescence antibody studies. Transplant Proc. 1973;5:1539–1542
  9. Van Bekkum DW, De Vries MJ. Radiation chimaeras. London: Logos Press; 1967;
  10. De Koning J, Dooren LJ, Van Bekkum DW, et al. Transplantation of bone marrow cells and fetal thymus in an infant with lymphopenic immunological deficiency. Lancet. 1969;1:1223–1226
  11. Speck B, Zwaan FE, Van Rood JJ, et al. Allogeneic bone marrow transplantation in a patient with aplastic anemia using a phenotypically HL-A–identical unrelated donor. Transplantation. 1973;16:24–28
  12. Speck B, Kissling M. Successful bone marrow grafts in experimental aplastic anemia using antilymphocytic serum for conditioning. Rev Eur Etud Clin Biol. 1971;10:1047–1051
  13. Eernisse JG, Van Rood JJ. Erythrocyte survival-time determination with the aid of DF32P. Br J Haematol. 1961;7:382–404
  14. Bosch LJ, Jansz A, Lammers HA, et al. Possibilities on the use of Cr-51 in the determination of the length of survival of thrombocytes. Ned Tijdschr Geneeskd. 1963;107:321–324
  15. Eernisse JG, Brand A. Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte poor blood components. Exp Hematol. 1981;9:77–83
  16. Van Rood JJ, Claas F. The influence of allogeneic cells on the human T and B cell repertoire. Science. 1990;248:1388–1393
  17. Van Rood JJ, Loberiza FR, Zhang M-J, et al. Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. Blood. 2002;99:1572–1577

PII: S0887-7963(06)00097-6

doi: 10.1016/j.tmrv.2006.11.006

Transfusion Medicine Reviews
Volume 21, Issue 2 , Pages 159-163 , April 2007

Article Tools

* Image Usage & Resolution